Flesh Hydrating SPF Serum

Manufacturer
Revlon Consumer Products Corporation | Englewood Lab, Inc.
Effective date
2020-04-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:04:31

Label at a glance#

ProductFlesh Hydrating SPF Serum
Active ingredientHOMOSALATE, OCTISALATE, AVOBENZONE
Label structure7 sections

Indications and uses

- Helps prevent submburn - If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancerand early skin aging caused by the sun.

Dosage and administration

- Apply liberally 15 minutes before sun exposure - Use a water resistant sunscreen if swimming or sweating - Reapply at least every 2 hours

Storage and handling

Protect this product from excessive heat and direct sun

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Avobenzone 3.0%

Homosalate 10.0%

Octisalate 5.0%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

OTC - PURPOSE SECTION

- Helps prevent submburn

- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancerand early skin aging caused by the sun.

Warnings

WARNINGS SECTION

- For external use only

- Do not use on danaged or broken skin

- When using this product keep out of eyes. Rinse with water to remove.

- Stop use and ask a doctor if rash occurs

- Keep out of reach of children. If swallowed get medical helpor contact a Poison Control Center right away.

Directions

INSTRUCTIONS FOR USE SECTION

- Apply liberally 15 minutes before sun exposure

- Use a water resistant sunscreen if swimming or sweating

- Reapply at least every 2 hours

Other Information

STORAGE AND HANDLING SECTION

Protect this product from excessive heat and direct sun

Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Flesh SPF serumFlesh SPF serum

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
1681bc73-b05f-12c3-1075-382ae39f449cProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10967-660-012021-07-23C16284748780-1c7ccaba7-19d7-fd44-e053-dadaa90aa01bFlesh Hydrating SPF Serum

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10967-660-01Flesh Hydrating SPF Serum30 mL in 1 PACKAGELOTION301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10967-660FLESH HYDRATING SPF SERUM (AVOBENZONE, HOMOSALATE, OCTISALATE) LOTION [REVLON CONSUMER PRODUCTS CORPORATION]1Legacy NDC, 1 package rows20200401_a009fe9d-af00-db85-e053-2995a90a9c77.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10967-66010967-660-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a009fe9d-af01-db85-e053-2995a90a9c77a009fe9d-af00-db85-e053-2995a90a9c772020-04-01WarningsExact identifier
spl id: a009fe9d-af01-db85-e053-2995a90a9c77
spl set id: a009fe9d-af00-db85-e053-2995a90a9c77

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.